Literature DB >> 1954884

Angiotensin-II receptor subtypes in median eminence and basal forebrain areas involved in regulation of pituitary function.

K Tsutsumi1, J M Saavedra.   

Abstract

We used quantitative autoradiography to characterize angiotensin-II (ANG-II) receptor subtypes in areas of the rat basal forebrain involved in pituitary control. ANG binding was totally displaced by the selective AT1 receptor subtype antagonist DuP 753 and was inhibited by dithiothreitol in median eminence, infundibular stem, paraventricular nucleus, subfornical organ, median preoptic nucleus, anterior pituitary, and the forebrain ANG-II receptor band, which extends from the subfornical organ to the vascular organ of the lamina terminalis, including the lamina terminalis and a continuous band of receptors reaching the paraventricular nucleus. In these areas, binding was not affected by the selective AT2 competitors PD 123177 or CGP 42112 A, indicating the presence of AT1 and the absence of AT2 receptors. AT1 binding was higher in the external layer and lateral parts of the median eminence. Conversely, ANG binding in the dura mater encapsulating the pituitary, in the vessels adjacent to this part of the dura mater, presumably branches of the hypophyseal arteries, and in anterior cerebral arteries was displaced by PD 123177 and CGP 42112 A, and was unaffected by dithiothreitol or DuP 753, indicating the presence of AT2 receptors in these structures. Our results implicate AT1 receptors in the central neural regulation of pituitary function. AT2 receptors may play a role in the regulation of blood flow to the basal forebrain and the pituitary gland.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954884     DOI: 10.1210/endo-129-6-3001

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Pharmacological characterization of angiotensin II AT(2) receptor subtype heterogeneity in the rat adrenal cortex and medulla.

Authors:  X Lu; K L Grove; W Zhang; R C Speth
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

Review 2.  Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli.

Authors:  J M Saavedra; I Armando
Journal:  Cell Mol Neurobiol       Date:  2017-09-07       Impact factor: 5.046

3.  Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress.

Authors:  Ines Armando; Simona Volpi; Greti Aguilera; Juan M Saavedra
Journal:  Brain Res       Date:  2007-01-19       Impact factor: 3.252

Review 4.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

5.  The cardiovascular response of normal rats to dual lesion of the subfornical organ and area postrema at rest and to chronic losartan.

Authors:  John P Collister; David B Nahey
Journal:  Brain Res       Date:  2009-09-16       Impact factor: 3.252

6.  Increased angiotensin II AT1 receptor mRNA and binding in spleen and lung of AT2 receptor gene disrupted mice.

Authors:  Jaroslav Pavel; José A Terrón; Julius Benicky; Alicia Falcón-Neri; Amita Rachakonda; Tadashi Inagami; Juan M Saavedra
Journal:  Regul Pept       Date:  2009-09-17

7.  In vivo Angiotensin II AT1 receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland.

Authors:  Enrique Sánchez-Lemus; Julius Benicky; Jaroslav Pavel; Juan M Saavedra
Journal:  Brain Behav Immun       Date:  2009-05-07       Impact factor: 7.217

8.  Angiotensin II AT(1) receptor blockade selectively enhances brain AT(2) receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats.

Authors:  C Bregonzio; A Seltzer; I Armando; J Pavel; J M Saavedra
Journal:  Stress       Date:  2008-11       Impact factor: 3.493

9.  A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH.

Authors:  Miroslava Macova; Jaroslav Pavel; Juan M Saavedra
Journal:  Brain Res       Date:  2008-11-12       Impact factor: 3.252

10.  Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo.

Authors:  Jaroslav Pavel; Julius Benicky; Yuki Murakami; Enrique Sanchez-Lemus; Juan M Saavedra
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.